FAD, an active form of riboflavin, promotes folding and conformational stabilization of ETFDH [4], and riboflavin deficiency decreases the amount of ETFDH protein in fibroblasts from late-onset MADD patients and healthy subjects. Here, ETFDH is linked to multiple acyl-CoA dehydrogenase deficiency.